G. Wells

发表

Protocol for the development of a CONSORT-equity guideline to improve reporting of health equity in randomized trials

P. Tugwell, V. Welch, J. Jull, 2015, Implementation Science.

OP0071 Risk of Cancer, Serious Lung Infections and Death with Biologics: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials (RCTS)

P. Tugwell, G. Wells, L. Maxwell, 2013 .

Minimal clinically important differences: review of methods.

B Shea, P Tugwell, P. Tugwell, 2001, The Journal of rheumatology.

Towards a definition of "difference" in osteoarthritis.

M. Dougados, B. Shea, G. Wells, 2001, The Journal of rheumatology.

Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations

G. Koch, P. Tugwell, C. Bombardier, 2008, Annals of the rheumatic diseases.

Should improvement in rheumatoid arthritis clinical trials be defined as fifty percent or seventy percent improvement in core set measures, rather than twenty percent?

G. Wells, D. Felson, J. Anderson, 1998, Arthritis and rheumatism.

Minimal clinically important difference module: summary, recommendations, and research agenda.

P. Tugwell, C. Bombardier, M. Dougados, 2001, The Journal of rheumatology.

Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration.

J J Anderson, G. Wells, D. Felson, 2000, Arthritis and rheumatism.

When is a randomised controlled trial health equity relevant? Development and validation of a conceptual framework

C Weijer, M Taljaard, B Shea, 2017, BMJ Open.

Looking for important change/differences in studies of responsiveness. OMERACT MCID Working Group. Outcome Measures in Rheumatology. Minimal Clinically Important Difference.

C. Bombardier, B. Shea, G. Wells, 2001, The Journal of rheumatology.

Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations.

P Tugwell, B Combe, G. Koch, 2008, Arthritis and rheumatism.

Methods of deriving EULAR/ACR recommendations on reporting disease activity in clinical trials of patients with rheumatoid arthritis

M. Dougados, G. Wells, D. Felson, 2008, Annals of the rheumatic diseases.

Electrical stimulation for the treatment of rheumatoid arthritis.

V. Welch, G. Wells, G. Wells, 2002, The Cochrane database of systematic reviews.

Endpoints in rheumatoid arthritis.

P. Tugwell, G. Wells, M. Boers, 1994, The Journal of rheumatology. Supplement.

The efficacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis. A metaanalysis of randomized controlled trials.

M. Suarez‐Almazor, P. Tugwell, P. Tugwell, 1998, The Journal of rheumatology.